WallStreetZenWallStreetZen

NASDAQ: NGM
Ngm Biopharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for NGM

Based on 4 analysts offering 12 month price targets for Ngm Biopharmaceuticals Inc.
Min Forecast
$4.00-25.93%
Avg Forecast
$12.00+122.22%
Max Forecast
$29.00+437.04%

Should I buy or sell NGM stock?

Based on 6 analysts offering ratings for Ngm Biopharmaceuticals Inc.
Buy
Strong Buy
1 analysts 16.67%
Buy
2 analysts 33.33%
Hold
3 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NGM stock forecasts and price targets.

NGM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Raymond James
Top 10%
91
BuyMaintains$6.00+11.11%2022-11-04
Cowen & Co.
Bottom 2%
2
BuyMaintains$9.00+66.67%2022-10-18
Goldman Sachs
Bottom 7%
7
HoldDowngrades$4.00-25.93%2022-10-18
Piper Sandler
Bottom 16%
16
HoldDowngradesN/AN/A2022-10-17
Jefferies
Bottom 14%
14
HoldDowngradesN/AN/A2022-10-17
B. Riley Securities
Top 1%
100
Strong BuyMaintains$29.00+437.04%2022-10-07
Anonymous
Goldman Sachs
Strong BuyMaintains$29.00+437.04%2022-05-24

1 of 1

Forecast return on equity

Is NGM forecast to generate an efficient return?
Company
N/A
Industry
-0.01%
Market
13.24%

Forecast return on assets

Is NGM forecast to generate an efficient return on assets?
Company
N/A
Industry
0.12%

NGM earnings per share forecast

What is NGM's earnings per share in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
-$2.49
Avg 2 year Forecast
-$2.27
Avg 3 year Forecast
-$2.21

NGM revenue forecast

What is NGM's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$33.3M
Avg 2 year Forecast
$52.9M
Avg 3 year Forecast
$218.1M

NGM vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NGM$5.40$12.00+122.22%Buy
LXRX$2.36$15.00+535.59%Strong Buy
ICVX$11.20$27.00+141.07%Buy
WVE$5.15$6.67+29.46%Hold
DSGN$8.01$24.00+199.63%Buy
View Top Biotech Stocks

Ngm Biopharmaceuticals Stock Forecast FAQ

Is Ngm Biopharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: NGM) stock is to Buy NGM stock.

Out of 6 analysts, 1 (16.67%) are recommending NGM as a Strong Buy, 2 (33.33%) are recommending NGM as a Buy, 3 (50%) are recommending NGM as a Hold, 0 (0%) are recommending NGM as a Sell, and 0 (0%) are recommending NGM as a Strong Sell.

If you're new to stock investing, here's how to buy Ngm Biopharmaceuticals stock.

What is NGM's earnings growth forecast for 2023-2025?

(NASDAQ: NGM) Ngm Biopharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.4%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 21.99%.

Ngm Biopharmaceuticals's earnings in 2023 is -$153,464,000.On average, 5 Wall Street analysts forecast NGM's earnings for 2023 to be -$203,498,021, with the lowest NGM earnings forecast at -$245,178,339, and the highest NGM earnings forecast at -$152,827,831. On average, 4 Wall Street analysts forecast NGM's earnings for 2024 to be -$185,518,277, with the lowest NGM earnings forecast at -$214,939,677, and the highest NGM earnings forecast at -$156,914,137.

In 2025, NGM is forecast to generate -$180,614,710 in earnings, with the lowest earnings forecast at -$211,670,633 and the highest earnings forecast at -$150,376,048.

What is NGM's revenue growth forecast for 2023-2025?

(NASDAQ: NGM) Ngm Biopharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.23%.

Ngm Biopharmaceuticals's revenue in 2023 is $0.On average, 4 Wall Street analysts forecast NGM's revenue for 2023 to be $2,721,479,563, with the lowest NGM revenue forecast at $980,713,356, and the highest NGM revenue forecast at $4,903,566,780. On average, 4 Wall Street analysts forecast NGM's revenue for 2024 to be $4,321,268,225, with the lowest NGM revenue forecast at $204,315,283, and the highest NGM revenue forecast at $11,253,685,760.

In 2025, NGM is forecast to generate $17,827,325,659 in revenue, with the lowest revenue forecast at $11,144,990,030 and the highest revenue forecast at $24,509,661,289.

What is NGM's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: NGM) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.

What is NGM's Price Target?

According to 4 Wall Street analysts that have issued a 1 year NGM price target, the average NGM price target is $12.00, with the highest NGM stock price forecast at $29.00 and the lowest NGM stock price forecast at $4.00.

On average, Wall Street analysts predict that Ngm Biopharmaceuticals's share price could reach $12.00 by Nov 4, 2023. The average Ngm Biopharmaceuticals stock price prediction forecasts a potential upside of 122.22% from the current NGM share price of $5.40.

What is NGM's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: NGM) Ngm Biopharmaceuticals's current Earnings Per Share (EPS) is -$1.95. On average, analysts forecast that NGM's EPS will be -$2.49 for 2023, with the lowest EPS forecast at -$3.00, and the highest EPS forecast at -$1.87. On average, analysts forecast that NGM's EPS will be -$2.27 for 2024, with the lowest EPS forecast at -$2.63, and the highest EPS forecast at -$1.92. In 2025, NGM's EPS is forecast to hit -$2.21 (min: -$2.59, max: -$1.84).

What is NGM's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: NGM) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.